Greg Brockman· @gdb · X·· 4 小时前AI 评分61
AI 导读
OpenAI 宣布收购 Orchestra Bio，这是一个帮助生物医药团队协调复杂药物研发流程的平台。双方将在 Rosalind 平台基础上结合 OpenAI 的模型与工具，简化相关运营，帮助新疗法更快惠及患者，团队负责人 @ashokaraj_ 等将加入。
正文 · 原文
towards acceleration of drug development, an extremely exciting and promising emerging application of our models
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! https://openai.com/index/openai-to-acquire-orchestra-bio/在 X 查看被引用的帖子
来源：Greg Brockman · x.com